UNCY Unicycive Therapeutics
- 1.0850
- -0.0050-0.46%
Unicycive Therapeutics News
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gupta Shalabh K.
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gupta Pramod
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jermasek Douglas
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend John
Unicycive Therapeutics | D: Filing D
Unicycive Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Unicycive Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%), etc.
Unicycive Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(2.73%),Steven Boyd(2.73%)
Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP(6.1%)
Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%), etc.
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Laumas Sandeep
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kenkare-Mitra Sara
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ryan John L
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Aggarwal Gaurav
Unicycive Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Kenkare-Mitra Sara
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gupta Pramod
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-CEO Gupta Shalabh K.
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Townsend John
Unicycive Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jermasek Douglas
Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vivo Opportunity Fund Holdings, L.P.(9.99%),Vivo Opportunity, LLC(9.99%)
Analysis
Price Target
No Data
